Response to Letter to the Editor: Left Gastric Artery Embolization for Weight Loss—a Dead-End Procedure

  • Martin FriedEmail author
  • Nodar Kipshidze
Letter to the Editor

To the Editor,

We have been following, with great interest, the continued and balanced discussion surrounding the results published by Bai et al., “Bariatric embolization of the left gastric artery for the treatment of obesity: 9-month data in 5 patients.”

Our interest was piqued by two key points.

Firstly, Bai and colleagues reported their first experience with a new approach to treat obesity, bariatric embolization [1]. There may be a treatment potential with this method that should not be hastily disqualified [2]. In fact, it could fit into an existing treatment gap between those who qualify for pharma/conservative treatment of obesity and those who qualify for established bariatric/metabolic procedures [3].

Secondly, our interest in this discussion is amplified by our own ongoing prospective, randomized, sham-controlled, single-blind trial involving 40 patients (BMI 35–50 kg/m2) whom consented for left gastric artery embolization (LGAE) using 300–500-μm microspheres through the...


Compliance with Ethical Standards

Conflict of Interest

Martin Fried was Principal Investigator of the RCT and Nodar Kipshidze was Endobar Solutions LLC Part-time consultant for statistical analysis.

Ethical Approval Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent Statement

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Bai ZB, Qin YL, Deng G, et al. Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obes Surg. 2018;28(4):907–15.CrossRefPubMedGoogle Scholar
  2. 2.
    Fink MJ, Martini V, Seifer G, et al. Left gastric artery embolization for weight loss-a dead-end procedure. Obes Surg. 2018;28(11):3623–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Angrisani L, Santonicola A, Vitello A, et al. Left gastric artery embolization for weight loss-a dead-end procedure. Obes Surg. 2018;28(11):3627–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Weiss CR, Akonwande O, Paudel K, et al. Clinical safety of bariatric arterial embolization:preliminary results of the BEAT obesity trial. Radiology. 2017;283(2):598–608.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kipshidze N, Archvadze A, Bertog S, et al. Endovascular bariatrics: first in humans study of gastric artery embolization for weight loss. JACC Cardiovasc Interv. 2015;8(12):1641–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Arepally A, Barnett BP, Montgomery E, et al. Catheter – directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience. Radiology. 2007;244(1):138–43.CrossRefPubMedGoogle Scholar
  7. 7.
    Arepally A, Barnett BP, Patel TH, et al. Catheter – directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model. Radiology. 2008;249(1):127–33.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bawudun D, Xing Y, Liu WY, et al. Ghrelin suppression and fat loss after left gastric artery embolizationin canine model. Cardiovasc Intervent Radiol. 2012;35(6):1460–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Syed MI, Morar K, Shaikh A, et al. Gastric artery embolization trial for lessening of apetite nonsurgically (GET LEAN): six month preliminary data. J Vasc Interv Radiol. 2016;27(10):1502–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.OB Klinika, Center for Treatment of Obesity and Metabolic DisordersPragueCzech Republic
  2. 2.New York UniversityNew YorkUSA

Personalised recommendations